Validation

Vena Recognized by Ventana Research as Vendor of Merit for Second Consecutive Year

Retrieved on: 
Thursday, November 2, 2023
TCO, Research, Vena, Business plan, Microsoft, Organization, Economic and Business Research Center, Senior, Environment, Validation, Business, Ventana, Forecasting, Microsoft Excel, Completeness, Automation, Risk management, Management

TORONTO, Nov. 2, 2023 /PRNewswire/ -- Vena, the Complete Planning platform loved by finance and trusted by business, announced today it has been listed as a Vendor of Merit by Ventana Research in its 2023 Buyers Guide for Business Planning. This is the second consecutive year Vena has received this ranking, scoring its highest marks in Customer Experience, Total Cost of Ownership/Return on Investment and Validation.

Key Points: 
  • This is the second consecutive year Vena has received this ranking, scoring its highest marks in Customer Experience, Total Cost of Ownership/Return on Investment and Validation.
  • This allows companies to be proactive in their financial and operational planning, rather than reactive to changes in the economic environment.
  • "Vena distinguished itself as a standout planning provider through its dedication to meeting the expanding needs of modern FP&A professionals," said Rob Kugel, Senior Vice President and Research Director of Business Research at Ventana Research.
  • "It is an honor to again be recognized as a Vendor of Merit by Rob's team at Ventana Research," said Hugh Cumming, Chief Technology Officer at Vena.

WatchGuard Launches MDR Service, Helps MSPs Accelerate Cybersecurity Service Delivery

Retrieved on: 
Tuesday, October 24, 2023
WatchGuard, Intelligence, SOC, Data collection, Unified, MSP, Face, Remedy, MDR, Detection, Nature, Guideline, Validation, Mitigation, Machine learning, Hunting, Member of the Scottish Parliament, AI, Education minister, Medical device, Risk management

SEATTLE, Oct. 24, 2023 (GLOBE NEWSWIRE) -- WatchGuard® Technologies , a global leader in unified cybersecurity, today announced the launch of WatchGuard MDR , a new 24/7 cybersecurity service purpose-built to make MDR vastly more accessible to managed service providers (MSPs) working to address soaring customer demand for managed cybersecurity delivery.

Key Points: 
  • SEATTLE, Oct. 24, 2023 (GLOBE NEWSWIRE) -- WatchGuard® Technologies , a global leader in unified cybersecurity, today announced the launch of WatchGuard MDR , a new 24/7 cybersecurity service purpose-built to make MDR vastly more accessible to managed service providers (MSPs) working to address soaring customer demand for managed cybersecurity delivery.
  • The new service is managed by an elite team of cybersecurity experts and powered by AI.
  • It requires no investment in a traditional security operation center (SOC) infrastructure, advanced technologies, or security experts, which addresses the pressures of scarce cybersecurity professionals and funding faced by MSPs.
  • Or they can outsource the initial response and the containment through endpoint isolation to automated playbooks developed by WatchGuard MDR experts.

Sinch Expands the Mailgun Product Suite with Mailgun Optimize and Mailgun Validate to Transform Email Deliverability

Retrieved on: 
Wednesday, October 25, 2023
Cloud, ESP, Optimization, Policy, MX, SPF, DKIM, Send, Mailgun, Rede Super, API, ROI, Representational state transfer, Titanium SDK, Validation, DMARC, Yahoo!, SMTP, SAN, Sales, Mail, Sinch

Mailgun is an industry leader in email delivery, with over 400 billion emails sent every year for the world's biggest brands and technology providers.

Key Points: 
  • Mailgun is an industry leader in email delivery, with over 400 billion emails sent every year for the world's biggest brands and technology providers.
  • Email deliverability is extremely complex and poised to become even more difficult with upcoming policy changes from major inbox service providers.
  • Mailgun Optimize and Mailgun Validate work seamlessly with Mailgun Send to bridge the complexities of delivery and deliverability, ensuring emails are reliably sent and landing in the primary inbox.
  • To learn more about the new product suite and try Mailgun for free, visit mailgun.com .

Veritas™ 360 Defense to Deliver Cyber Resilience On-Prem and Across Clouds

Retrieved on: 
Monday, October 23, 2023
Data Management, Security, Technology, Software, Networks, Internet, AD, Ecosystem, Veritas Technologies, Rio (hotel and casino), Active Directory, Architecture, Face, PwC, Organization, Dreamscape, Data management, CrowdStrike, Information technology, Environment, Validation, Falcon, Risk, Confusion, API, Defense, Video game, Risk management, Cryptocurrency, Online shopping, Qualys, Kubernetes, Veritas, CyberArk, Broadcom Inc., Symantec

Veritas Technologies , the leader in secure multi-cloud data resilience, today announced Veritas 360 Defense, the first extensible architecture in its space that brings together leading data protection, data governance, and data security capabilities.

Key Points: 
  • Veritas Technologies , the leader in secure multi-cloud data resilience, today announced Veritas 360 Defense, the first extensible architecture in its space that brings together leading data protection, data governance, and data security capabilities.
  • Veritas 360 Defense delivers a unique set of cyber resilience capabilities integrated with leading security vendors, such as CrowdStrike , CyberArk , Qualys , Semperis and Symantec by Broadcom .
  • Veritas 360 Defense has been battle tested against real-world ransomware variants in the Veritas REDLab.
  • Integrated with Veritas™ 360 Defense, Qualys Vulnerability Management, Detection and Response (VMDR) with Integrated Patch Management capabilities delivers the best cyber resilience on-prem and across the cloud."

Spring Health announces Atlas, the first recommendation engine for workplace mental and behavioral health

Retrieved on: 
Thursday, October 19, 2023
Health, Human resources, ROI, Trust, Validation, Machine learning, HR, Benchmarking, Algorithm, Investment, Mental health, Risk management, Nursing

NEW YORK, Oct. 19, 2023 /PRNewswire/ -- Spring Health, the most comprehensive global mental health solution for employers and health plans, today announced Atlas, a first-of-its-kind connected platform that empowers Human Resources teams and benefits leaders to optimize program outcomes and maximize return on investment for behavioral health.

Key Points: 
  • NEW YORK, Oct. 19, 2023 /PRNewswire/ -- Spring Health, the most comprehensive global mental health solution for employers and health plans, today announced Atlas, a first-of-its-kind connected platform that empowers Human Resources teams and benefits leaders to optimize program outcomes and maximize return on investment for behavioral health.
  • "Atlas arms HR executives with the evidence they need to make smart investments in their behavioral health programs," said Adam Chekroud, President and Co-Founder of Spring Health.
  • Spring Health is committed to partnerships with employers and health plans built on trust and transparency to improve organizational mental health.
  • The Validation Institute recently certified Spring Health as the first and only comprehensive mental health solution to show net savings for customers.

ValGenesis Presents Impressive Series of Innovations at ValConnect 2023, its Annual User Conference

Retrieved on: 
Tuesday, October 17, 2023
Integra, Validation, Intelligence, Qualification, CSO, Business process management, Product management, Engineering, Adviser, Associate Director of National Intelligence and Chief Information Officer, Patient, FDA, Ecosystem, Integra LifeSciences, Quality, Shaw, Thought, KPMG, Computer, Management, Dexcom, Alkermes

CLEARWATER, Fla., Oct. 17, 2023 /PRNewswire/ -- ValGenesis successfully concluded its annual user conference on Thursday, September 28th, having presented an impressive series of product innovations for 2024 to customers, partners, and industry experts.

Key Points: 
  • CLEARWATER, Fla., Oct. 17, 2023 /PRNewswire/ -- ValGenesis successfully concluded its annual user conference on Thursday, September 28th, having presented an impressive series of product innovations for 2024 to customers, partners, and industry experts.
  • ValGenesis' Vice President of Product Management, Kevin Shaw, kicked off this year's conference with an overview of 2023 and product roadmap for 2024.
  • "ValGenesis will converge them in a new 'Smart Validation' platform, the industry's only unified platform for manufacturing intelligence.
  • ValConnect is an essential conduit for the company's stakeholders to interact, helping them connect, trade ideas, and learn from one another.

Dermavant Announces New Positive Pruritus Data for VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as Two Years Old with Atopic Dermatitis at the EADV Congress 2023

Retrieved on: 
Thursday, October 12, 2023
Medical Supplies, Health, Other Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Congress, Journal of the European Academy of Dermatology and Venereology, Validation, Therapy, Caregiver, Atopic dermatitis, JD, Ageing, Addiction severity index, Itch, Patient, QD, EASI, Body surface area, Pharmaceutical industry, Dermatology, MD, Venereology

The new data presented at EADV 2023 contains daily recorded PP-NRS scores of patients in ADORING 1 and ADORING 2 on VTAMA cream for the first time.

Key Points: 
  • The new data presented at EADV 2023 contains daily recorded PP-NRS scores of patients in ADORING 1 and ADORING 2 on VTAMA cream for the first time.
  • Patients aged ≥12 years old self-completed the PP-NRS, while caregivers completed it for children aged
  • Improvements in daily PP-NRS scores with tapinarof versus vehicle continued through the first 2 weeks and through Week 8 of both trials.
  • Indication: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults.

Dermavant to Present Data from ADORING 1 and 2 Pivotal Phase 3 Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children as Young as 2 Years Old with Atopic Dermatitis at the 2023 EADV Congress

Retrieved on: 
Friday, October 6, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Cream, Linda, Congress, Incidence, Pain, Common, News, Journal of the European Academy of Dermatology and Venereology, Food, Itch, Prescription, Treatment, Atopic dermatitis, Late, Validation, Therapy, Pivotal, Rash, Stinger, Safety, Psoriasis, Headache, FDA, Swelling, Psoriasis Area and Severity Index, Nose, Political moderate, Regulation of tobacco by the U.S. Food and Drug Administration, Irritation, Folliculitis, Week, Dietary supplement, Dermatology, Venereology

The following late-breaking oral presentations will be presented live during the Late Breaking News sessions on October 11 and October 12, 2023 and will be available on the EADV virtual platform.

Key Points: 
  • The following late-breaking oral presentations will be presented live during the Late Breaking News sessions on October 11 and October 12, 2023 and will be available on the EADV virtual platform.
  • This oral presentation will include data on the efficacy endpoints that evaluated itch relief of VTAMA® (tapinarof) cream, 1% once daily (QD) in ADORING 1 and 2 based on mean daily and mean weekly changes in Peak Pruritus Numeric Rating Scale (PP-NRS) scores through Week 8.
  • You are encouraged to report negative side effects of prescription drugs to the FDA.
  • Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Global General Purpose Electronic Test and Measurement Instruments Market Expected to Reach $15.6 Billion by 2030, With a Strong CAGR of 9.6%

Retrieved on: 
Saturday, October 14, 2023
COVID-19, Validation, Real, High performance organization, SCSI Peripheral Device Type, Marketplace, Risk, Market, Measurement, Internet of things, Framework Programmes for Research and Technological Development, Electronic Products, Video game, Medical device

Impact of COVID-19 Pandemic and Looming Global Recession; Living with COVID-19, the New Normal

Key Points: 
  • Impact of COVID-19 Pandemic and Looming Global Recession; Living with COVID-19, the New Normal
    Stagflation and Risk of Recession: New Challenges Emerge for the Global Market in 2022 & 2023
    World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020, 2021, 2022 and 2023
    What Does it Take To Survive in the Marketplace?
  • Global Digital Storage Oscilloscopes Market Share Breakdown by Competitor: 2022
    Global Network Analyzers Market Revenue Breakdown (in %) by Leading Competitors: 2022
    Global Spectrum Analyzers Market Revenue Share Breakdown by Company: 2022
    Electronic Test & Measurement Instruments: Indispensable for Validation of Performance and Functioning of Electronic Products
    General Purpose Electronic T&M Instruments: Product Overview
    Product Innovations & Technology Developments: Spearheading Growth in Oscilloscopes Market
    Extension Based T&M Instruments Market: A Review
    Global PXI Test and Measurement Equipment Market Share Breakdown by Product Segment: 2022
    Cost-Effective and High Performance Instruments: Essential for Manufacturing Applications
    Global Number of IoT Connected Devices (In Billion) for the Years 2016, 2018, 2020, 2022 & 2025
    Opportunity Indicator: Global Spending (In US$ Billion) on IoT for the Years 2019, 2020, 2021, 2022 & 2024
    Global 5G Subscriptions (In Million) for Years 2020, 2022, 2024 and 2026
    Global Smartphone Subscription Breakdown by Technology: 2019 and 2025
    Worldwide Mobile Data Traffic by Device Type (in %) for 2016, 2018 and 2020

Blue Mountain Enhances Life Sciences Manufacturing with Introduction of Innovative Partner Program at 2023 Customer Summit

Retrieved on: 
Tuesday, September 26, 2023
GMP, Blue Mountain, Good, Professional services, Validation, Good manufacturing practice, Health, Calibration, Biotechnology, EM, Research, PCI, Blue, Engineering, Design, Architecture, Microbiology, Blue Mountains walking tracks, Industrial design, Interior design, Construction, Pharmaceutical industry, Certification

STATE COLLEGE, Pa., Sept. 26, 2023 /PRNewswire/ -- Blue Mountain, the leading provider of Good Manufacturing Practice (GMP) compliance software for the Life Sciences industry, made a major announcement at their annual international customer summit, unveiling their new partner program.

Key Points: 
  • STATE COLLEGE, Pa., Sept. 26, 2023 /PRNewswire/ -- Blue Mountain, the leading provider of Good Manufacturing Practice (GMP) compliance software for the Life Sciences industry, made a major announcement at their annual international customer summit, unveiling their new partner program.
  • "We are thrilled to unveil the Blue Mountain Partner Program at this year's Blue Mountain Customer Summit," said David Rode, CEO of Blue Mountain.
  • Key client benefits of the Blue Mountain Partner Program include:
    Accelerated Time to Launch: Blue Mountain Services Partners offer their subject matter expertise, industry insights, and best practices, ensuring expedited and seamless implementations.
  • For additional information about the Blue Mountain Partner Program, please visit www.coolblue.com/partner or email [email protected]